제이에스링크

127120KOSDAQ

51.8 / 100

Reference Date: 2026-09-08

Financial Score12.5 / 40

News Sentiment21.3 / 25

Momentum8.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Plunged 17.2% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

JS Link operates in genomics analysis, personalized medicine, and diagnostics, leveraging advancements in genomic technology and rising demand for customized treatments. As genome sequencing costs have drastically decreased and bioinformatics becomes crucial for handling large data, the molecular diagnostics market is rapidly expanding. Establishing Asia-specific genomic databases is key to securing global competitiveness.

Number of Employees

139people

Average Salary

53.5M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 15.004.0Point

PBR

17.30Industry Average 1.200.0Point

14.4x industry avg (risky)

ROE

-35.13Industry Average 8.000.0Point

Well below industry avg

Debt Ratio

9.28Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20250.5 / 10 points

Revenue Growth Rate

0.5 / 3

Avg ▼3.0% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼73.4% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -32.6% (declining, 3yr)

Detailed News Sentiment

1 totalPositive 1Neutral 0Negative 0Average Sentiment Score 85

Positive
호주 희토류·한국 기술력으로 영구자석 만든다
제이에스링크는 호주와의 협력으로 한국 기술력을 활용해 영구자석 생산을 확대하고, 글로벌 시장 진출을 가속화하여 긍정적인 성장 전망을 보임.

Detailed Momentum

52-week position5.0Point

52w mid range (49%)

Current 32,400Won52-week high 48,90052-week low 16,050

1-month return0.0Point

1m -17.24% (strong drop)

Volume trend3.0Point

Volume flat

Detailed Disclosure

5 totalPositive 0Neutral 5Negative 0

Neutral[기재정정]타법인주식및출자증권취득결정2026-08-31
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-08-31
Neutral주식매수선택권행사2026-08-25
Neutral주요사항보고서(자기전환사채만기전취득결정)2026-08-24
Neutral반기보고서 (2026.06)2026-08-14